Open AccessTherapeutic Drug Monitoring in the Treatment of Active Tuberculosis
Author(s) -
Aylin Babalık,
Sharyn Mannix,
Denis Francis,
Dick Menzies
Publication year - 2011
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2011/307150
Subject(s) - medicine , tuberculosis , drug , intensive care medicine , therapeutic drug monitoring , active tuberculosis , medline , mycobacterium tuberculosis , pharmacology , pathology , political science , law
Therapeutic drug monitoring (TDM) is used to optimize dosing that maximizes therapeutic benefit while minimizing toxicity. In the treatment of active tuberculosis (TB), TDM is not routine, yet low levels of anti-TB drugs can be associated with poorer treatment outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom